CIRB Studies
Below is the current list of studies covered by the CIRB. It includes both Available to Open and Completed studies. Study documents approved after July 1, 2013 for all covered studies are available on the CTSU website.
To request documents approved before July 1, 2013, please contact the CIRB Helpdesk.
Study Number | Lead Group | Study Title | CIRB | Study Status |
---|---|---|---|---|
EA1151 | ECOG-ACRIN | Tomosynthesis Mammographic Imaging Screening Trial (TMIST) | Cancer Prevention and Control CIRB | Available to Open |
NWU2017-09-01 | CLO-Northwestern University | Phase I trial of endoxifen gel versus placebo gel in women undergoing breast surgery | Cancer Prevention and Control CIRB | Available to Open |
NRG-CC008 | NRG | A Non-Randomized Prospective Clinical Trial Comparing the Non-Inferiority of Salpingectomy to Salpingo-oophorectomy to Reduce the Risk of Ovarian Cancer Among BRCA1 Carriers [SOROCk] | Cancer Prevention and Control CIRB | Available to Open |
NRG-CC003 | NRG | Randomized Phase II/III Trial of Prophylactic Cranial Irradiation with Or without Hippocampal Avoidance for Small Cell Lung Cancer | Cancer Prevention and Control CIRB | Available to Open |
EAQ171CD | ECOG-ACRIN | Implementing a Virtual Tobacco Treatment in Community Oncology Practices: “Smoke Free Support Study 2.0” | Cancer Prevention and Control CIRB | Available to Open |
UAZ20-01-02 | CP-CTNet_CLO-University of Arizona | An extended follow-up study of the HPV vaccine delayed booster trial | Cancer Prevention and Control CIRB | Available to Open |
UWI2014-03-01 | CP-CTNet_CLO-University of Wisconsin | A Phase I Trial of the Safety and Immunogenicity of a DNA Plasmid Based Vaccine (WOKVAC) Encoding Epitopes Derived from Three Breast Cancer Antigens (IGFBP-2, HER2, AND IGF-1R) in Patients with Breast Cancer | Cancer Prevention and Control CIRB | Available to Open |
A191901 | Alliance | Optimizing Endocrine Therapy Through Motivational Interviewing and Text Interventions | Cancer Prevention and Control CIRB | Available to Open |
MDA20-02-01 | CP-CTNet_CLO-MD Anderson | Time Restricted Eating And Metformin (TEAM) in Invasive Breast Cancer (IBC) or Ductal Carcinoma in Situ (DCIS). A randomized, Phase IIb, Window of Opportunity Presurgical Trial. | Cancer Prevention and Control CIRB | Available to Open |
INT22-09-01 | CP-CTNet_CLO-University of Wisconsin | A Randomized Trial of Apalutamide in Non-Muscle Invasive Bladder Cancer | Cancer Prevention and Control CIRB | Available to Open |